Higher Court Allows Krka to Sell Valsacor
Ljubljana, 28 July - The Ljubljana Higher Court turned down the complaint of Swiss drug maker Novartis and confirmed the decision of the Ljubljana District Court issued in February not to ban Krka's production and sale of valsartan-based drug valsacor, Slovenian drug maker Krka wrote in a press release on Tuesday.
The rest of this news item is available to subscribers.
The news item consists of 311 characters (without spaces) or 62 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.